Skip to main
LQDA

LQDA Stock Forecast & Price Target

LQDA Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 75%
Buy 13%
Hold 0%
Sell 13%
Strong Sell 0%

Bulls say

Liquidia is poised for continued success as Yutrepia's sales and potential for expansion and new uses are strong, and the company's innovative technology and potential improvements to their product have positioned them well in the market.

Bears say

Liquidia is facing increasing competition in the inhaled prostacyclin market and their main product YUTREPIA has shown only marginal cough reduction compared to other DPIs, despite repeat prescribing behavior. They are also heavily relying on the success of their investigational product L606, which may face difficulties in the market as newer, more convenient options become available. Additionally, the outcome of ongoing patent litigation poses a significant risk to the company's success and continued growth.

LQDA has been analyzed by 8 analysts, with a consensus rating of Buy. 75% of analysts recommend a Strong Buy, 13% recommend Buy, 0% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Liquidia Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Liquidia Technologies Inc (LQDA) Forecast

Analysts have given LQDA a Buy based on their latest research and market trends.

According to 8 analysts, LQDA has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $49.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $49.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Liquidia Technologies Inc (LQDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.